-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Hepatitis C is a liver disease caused by the hepatitis C virus (HCV), which is spread mainly through needles and contact with blood products
Hepatitis C infection
Globally, an estimated 71 million people suffer from chronic HCV, of which 10 million live in sub-Saharan Africa.
Recently, Hui Kang Sangge Institute, MRC- Virus Research Center, University of Glasgow, jointly published in Hepatology study on the discovery led to HCV in three kinds of new strains , the study results may be for the world of HCV to provide information therapy and vaccine development, and to assist The World Health Organization has achieved the goal of eliminating HCV globally .
Hepatology Hepatology found that discovery lead to cause of the three kinds of three kinds of new strain new strain , , the study of the study results result possible for the whole world may be around the world to provide information on treatment and vaccine development, and to assist the World Health Organization to achieve therapeutic and vaccine development to provide information and assist the World Health Organization to achieve elimination in the world in the global elimination target
In 2016, the World Health Organization announced that its goal is to eliminate the public health problem of HCV on a global scale by 2030
diagnosis
This study is the largest study of HCV among the general population in sub-Saharan Africa so far.
Screening
Ugandan group characteristics
Ugandan group characteristicsStudies have shown that many existing virus strains carry genetic mutations that are known to be related to resistance to some commonly used antiviral drugs, which proves that cautious methods are needed to effectively diagnose and treat HCV in Africa
The goal now is to work together to determine the characteristics of HCV strains in sub-Saharan Africa at the population level, in order to assist countries in choosing the best treatment methods for national procurement
These studies emphasize the need for more investment in people in Africa and the developing regions of the world
Article reference: Chris Davis, George S.
Chris Davis, George S.
Leave a message here
